Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis

Keyphrases

• Multi-Ethnic Study of Atherosclerosis 100%
• Kidney Function 100%
• Lipoproteins 100%
• Cystatin C (Cys C) 100%
• Lipoprotein Abnormalities 100%
• Low-density Lipoprotein Particle 100%
• Lipid Biomarkers 66%
• Nuclear Magnetic Resonance 66%
• Diabetes 33%
• Community-based 33%
• Lipids 33%
• Cardiovascular Disease 33%
• Kidney Disease 33%
• Impaired Fasting Glucose 33%
• End-stage Renal Disease 33%
• Race-ethnicity 33%
• Renal Impairment 33%
• Albuminuria 33%
• Low-density Lipoprotein Cholesterol (LDL-C) 33%
• Risk for Cardiovascular Diseases 33%
• Body Mass Index 33%
• Kidney Disease Progression 33%
• Possible Causes 33%
• Triglyceride Level 33%
• High-density Lipoprotein Cholesterol (HDL-C) 33%
• Particle Distribution 33%
• Estimated Glomerular Filtration Rate 33%
• C Concentration 33%
• Lipoprotein Subclasses 33%
• Lipoprotein Metabolism 33%
• Low-density Lipoprotein Particle Size 33%
• Lipoprotein Particles 33%
• Impaired Kidney Function 33%
• Intermediate-density Lipoprotein 33%
• Cholesterol Levels 33%
• Serum Cystatin C 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Atherosclerosis 100%
• Lipoprotein 100%
• Low Density Lipoprotein 66%
• Cystatin C 66%
• Kidney Disease 33%
• Cardiovascular Disease 33%
• Disease Exacerbation 16%
• Triacylglycerol 16%
• End Stage Renal Disease 16%
• Low Density Lipoprotein Cholesterol 16%
• Albuminuria 16%
• High Density Lipoprotein Cholesterol 16%
• Intermediate Density Lipoprotein 16%